Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers

NCT07182214 is registered in ClinicalTrials.gov with Pharus Taiwan, Inc. as lead sponsor.

NCT NCT07182214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07182214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers
Lead sponsor
Pharus Taiwan, Inc.
Phase
Observational
Overall status
Recruiting
Start date
May 5, 2024
Completion date
December 31, 2026
Enrollment
1,340 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer